D. T. Walz

1.6k total citations
45 papers, 1.3k citations indexed

About

D. T. Walz is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, D. T. Walz has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in D. T. Walz's work include Pharmacological Effects of Medicinal Plants (4 papers), Venomous Animal Envenomation and Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). D. T. Walz is often cited by papers focused on Pharmacological Effects of Medicinal Plants (4 papers), Venomous Animal Envenomation and Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). D. T. Walz collaborates with scholars based in Canada, United States and United Kingdom. D. T. Walz's co-authors include Michael J. DiMartino, Anne Misher, Blaine M. Sutton, Don E. Griswold, Alan J. Lewis, A.P. Intoccia, William O. Foye, Lawrence W. Chakrin, David A. Williams and William Schallek and has published in prestigious journals such as The American Journal of Medicine, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

D. T. Walz

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. T. Walz Canada 19 314 279 253 188 182 45 1.3k
Michael J. DiMartino United States 24 375 1.2× 407 1.5× 323 1.3× 162 0.9× 215 1.2× 52 1.6k
Lewis Tanenbaum United States 12 466 1.5× 216 0.8× 161 0.6× 88 0.5× 238 1.3× 18 2.1k
Thomas J. Carty United States 21 561 1.8× 201 0.7× 133 0.5× 214 1.1× 609 3.3× 41 1.5k
J.M. te Koppele Netherlands 22 524 1.7× 223 0.8× 272 1.1× 297 1.6× 136 0.7× 54 1.8k
Anne Misher United States 11 161 0.5× 89 0.3× 88 0.3× 90 0.5× 93 0.5× 18 597
Miljana Momčilović Serbia 25 371 1.2× 173 0.6× 247 1.0× 71 0.4× 139 0.8× 52 1.3k
M. W. Whitehouse Australia 14 316 1.0× 172 0.6× 70 0.3× 51 0.3× 73 0.4× 26 819
Atif Zafar India 16 418 1.3× 119 0.4× 166 0.7× 330 1.8× 101 0.6× 28 1.2k
Teruyuki Kawabata Japan 19 430 1.4× 83 0.3× 226 0.9× 37 0.2× 45 0.2× 35 1.2k
Gangduo Wang United States 25 868 2.8× 115 0.4× 202 0.8× 165 0.9× 68 0.4× 48 1.6k

Countries citing papers authored by D. T. Walz

Since Specialization
Citations

This map shows the geographic impact of D. T. Walz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. T. Walz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. T. Walz more than expected).

Fields of papers citing papers by D. T. Walz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. T. Walz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. T. Walz. The network helps show where D. T. Walz may publish in the future.

Co-authorship network of co-authors of D. T. Walz

This figure shows the co-authorship network connecting the top 25 collaborators of D. T. Walz. A scholar is included among the top collaborators of D. T. Walz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. T. Walz. D. T. Walz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walz, D. T., et al.. (1983). Biologic actions and pharmacokinetic studies of auranofin. The American Journal of Medicine. 75(6). 90–108. 75 indexed citations
2.
Lewis, Alan J. & D. T. Walz. (1982). 1 Immunopharmacology of Gold. Progress in medicinal chemistry. 19. 1–58. 58 indexed citations
3.
Griswold, Don E., Sarah Alessi, Edward F. Webb, & D. T. Walz. (1982). Inhibition of carrageenan-induced inflammation by urethan anesthesia in adrenalectomized and shamoperated rats. Journal of Pharmacological Methods. 8(2). 161–164. 16 indexed citations
4.
Nathan, Ilana, et al.. (1982). Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregation. Inflammation. 6(1). 79–85. 13 indexed citations
5.
Walz, D. T., et al.. (1979). Distribution of gold in blood following administration of auranofin (SK&F D-39162).. PubMed. 5. 56–60. 18 indexed citations
6.
Burrone, Óscar R., et al.. (1977). Effect of auranofin on DNA and protein synthesis in human lymphocytes.. PubMed. 4(3). 245–51. 38 indexed citations
7.
Walz, D. T., et al.. (1977). Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes. Inflammation. 2(2). 143–150. 40 indexed citations
8.
Walz, D. T., Michael J. DiMartino, Lawrence W. Chakrin, Blaine M. Sutton, & Anne Misher. (1976). Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 197(1). 142–52. 62 indexed citations
9.
Walz, D. T., Michael J. DiMartino, Lawrence W. Chakrin, Blaine M. Sutton, & Anne Misher. (1976). Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.. Journal of Pharmacology and Experimental Therapeutics. 197(1). 142–152. 10 indexed citations
10.
Brune, Kay, et al.. (1974). A pharmacokinetic slide rule for more accurate drug treatment. European Journal of Clinical Pharmacology. 7(3). 233–239. 2 indexed citations
11.
Walz, D. T., et al.. (1974). The Anti-Inflammatory Effect of Heterologous Anti-Polymorphonuclear Leucccyte Serum on Adjuvant-Induced Arthritis. Experimental Biology and Medicine. 145(3). 1042–1046. 1 indexed citations
12.
Sutton, Blaine M., et al.. (1972). Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes. Journal of Medicinal Chemistry. 15(11). 1095–1098. 167 indexed citations
13.
Walz, D. T., Michael J. DiMartino, Blaine M. Sutton, & Anne Misher. (1972). SK&F 36914-AN AGENT FOR ORAL CHRYSOTHERAPY. Journal of Pharmacology and Experimental Therapeutics. 181(2). 292–297. 2 indexed citations
14.
Walz, D. T. & Michael J. DiMartino. (1972). Effect of Anti-Arthritic Drugs on Sulfhydryl Reactivity of Rat Serum. Experimental Biology and Medicine. 140(1). 263–268. 13 indexed citations
15.
Walz, D. T., Michael J. DiMartino, Blaine M. Sutton, & Anne Misher. (1972). SK&F 36914--an agent for oral chrysotherapy.. PubMed. 181(2). 292–7. 36 indexed citations
16.
Walz, D. T., Michael J. DiMartino, & Anne Misher. (1971). ADJUVANT-INDUCED ARTHRITIS IN RATS. II. DRUG EFFECTS ON PHYSIOLOGIC, BIOCHEMICAL AND IMMUNOLOGIC PARAMETERS. Journal of Pharmacology and Experimental Therapeutics. 178(1). 223–231. 103 indexed citations
17.
Walz, D. T., et al.. (1971). Suppression of adjuvant-induced arthritis in the rat by gold sodium thiomalate.. Annals of the Rheumatic Diseases. 30(3). 303–306. 29 indexed citations
18.
Walz, D. T., et al.. (1970). Arthritis and Psoriasis: The Effects of Antipsoriatic Agents in the Adjuvant-Induced Arthritic Rat. Experimental Biology and Medicine. 135(3). 760–762. 2 indexed citations
19.
Walz, D. T. & Gertrude D. Maengwyn‐Davies. (1960). THE MECHANISM OF ISOPROTERENOL VASOMOTOR REVERSAL BY PHENYLEPHRINE. Journal of Pharmacology and Experimental Therapeutics. 129(2). 208–213. 2 indexed citations
20.
Walz, D. T., Theodore Koppányi, & Gertrude D. Maengwyn‐Davies. (1960). ISOPROTERENOL VASOMOTOR REVERSAL BY SYMPATHOMIMETIC AMINES. Journal of Pharmacology and Experimental Therapeutics. 129(2). 200–207. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. DiMartino Breakdown of academic impact, for papers by Lewis Tanenbaum Breakdown of academic impact, for papers by Thomas J. Carty Breakdown of academic impact, for papers by J.M. te Koppele Breakdown of academic impact, for papers by Anne Misher Breakdown of academic impact, for papers by Miljana Momčilović Breakdown of academic impact, for papers by M. W. Whitehouse Breakdown of academic impact, for papers by Atif Zafar Breakdown of academic impact, for papers by Teruyuki Kawabata Breakdown of academic impact, for papers by Gangduo Wang
Rankless by CCL
2026